Cell Line Development
Welcome to our cell line development service, where cutting-edge science meets the demands of the modern biopharmaceutical industry. Our platform offers tailored solutions for developing high-yield, stable cell lines, including CHO, HEK, P. pastoris, and E. coli, designed for the production of monoclonal antibodies (mAbs), complex biotherapeutics, proteins, enzymes, and other biologics. Leveraging advanced technologies such as in-house combinational genetic element libraries, AI-assisted codon optimization, and high-throughput cell engineering with CRISPR, we provide a robust foundation for therapeutic innovation across a variety of cell systems.
Why Choose Our CLD Services?
To meet the demands for precision, reliability, and cost-effectiveness in cell line development, our expertise addresses these needs by offering:
• Customized Solutions: We design cell lines tailored to the specific requirements of each customer, ensuring optimal protein expression, high yield, and scalability across mammalian, yeast, and bacterial systems.
• Advanced Technology: Utilizing the latest in cell culture systems, screening technologies, bioprocess optimization, and AI-assisted codon optimization, we deliver cell lines that set new industry standards for efficiency and quality.
• Cost-Effectiveness: Our strategic approach reduces the time and cost associated with traditional cell line development, making high-quality solutions to be accesiable.
What We Offer
Our services are built to address the diverse needs of the pharmaceutical, biotechnology, and industrial sectors through a comprehensive suite of services:
• Rapid Cell Line Development: From transfection to screening, our streamlined process ensures the delivery of high-performing cell lines within the shortest possible timeframe.
• Cell Line Optimization: Beyond development, we refine and enhance cell lines for improved stability, productivity, and regulatory compliance.
- Mammalian cell lines, especially HEK (Human Embryonic Kidney) and CHO (Chinese Hamster Ovary) cells. Our expertise in cloning and mammalian cell lines ensures that these cells achieve high protein expression levels with exceptional scalability and long-term stability, making them ideal for commercial production. Whether you are producing gene therapies, biologics, or therapeutic proteins, our cell lines deliver consistent, high-quality results.
- Our bacterial E. coli cell lines are designed for the rapid production of recombinant proteins, enzymes, and peptides. With our efficient and cost-effective solutions, these E. coli cell lines ensure high yield in a short timeframe.
- Our Pichia pastoris cell lines provide an eukaryotic system for protein expression, especially for glycoproteins and therapeutic proteins. P. pastoris offers post-translational modifications similar to mammalian systems but with greater cost efficiency. These yeast cell lines offer scalability, reliability, and versatility for protein expression.
• High Throughput Cell Engineering with CRISPR (Coming Soon): Utilizing CRISPR technology, we will provide precise gene editing and rapid screening to generate custom cell lines with enhanced characteristics for biomanufacturing.
Your Partner in Biopharmaceutical Success
With a mission to empower the industry, our platform is more than a service provider—it’s a partner in your success. By choosing us, you gain access to a team of experts committed to delivering results that exceed expectations. Whether you need a cell line for producing complex molecules or a partner to optimize your biomanufacturing processes, we are here to help turn your vision into reality.